AVTX
Avalo Therapeutics Inc.
$11.70
-$0.13(-1.10%)
90
Overall
80
Value
100
Tech
--
Quality
Market Cap
$155.59M
Volume
262.02K
52W Range
$3.39 - $16.00
Target Price
$33.67
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | -- | $1.2M | $27.8M | $7.0M | $6.8M | $6.7M | $5.4M | $18.1M | $1.9M | $441.0K | ||
| Total Revenue | -- | $1.2M | $27.8M | $7.0M | $6.8M | $6.7M | $5.4M | $18.1M | $1.9M | $441.0K | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | -- | -- | $-635.6K | $-3.3M | $772.5K | $300.0K | $1.5M | $3.4M | $1.3M | $-366.0K | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | -- | $1.2M | $27.2M | $77.6K | $6.0M | $6.4M | $3.9M | $14.6M | $1.9M | $441.0K | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-11.0M | $-17.2M | $-13.9M | $35.6M | $23.4M | $77.5M | $84.5M | $52.1M | $24.1M | $41.7M | ||
| Research & Development | $6.6M | $10.1M | $4.4M | $24.5M | $11.8M | $57.7M | $59.8M | $31.3M | $13.8M | $24.4M | ||
| Research Expense | $6.6M | $10.1M | $4.4M | $24.5M | $11.8M | $57.7M | $59.8M | $31.3M | $13.8M | $24.4M | ||
| Selling, General & Administrative | $4.4M | $7.1M | $8.5M | $11.1M | $11.6M | $19.8M | $24.7M | $20.7M | $10.3M | $17.2M | ||
| Selling & Marketing Expenses | -- | -- | $569.8K | $545.2K | $1.5M | $2.3M | $2.8M | -- | -- | -- | ||
| General & Administrative Expenses | $4.4M | $7.1M | $7.9M | $10.5M | $10.1M | $17.4M | $24.7M | $20.7M | $10.3M | $17.2M | ||
| Salaries & Wages | $-394.7K | $-1.7M | $-1.2M | $-2.4M | $-2.5M | -- | -- | -- | $3.5M | $5.9M | ||
| Depreciation & Amortization | $-23.5K | $-26.9K | $400.0K | $-22.5K | $-119.5K | $100.0K | $100.0K | $38.0K | $200.0K | $200.0K | ||
| Depreciation & Amortization | $-23.5K | $-26.9K | $400.0K | $4.5M | $-119.5K | $100.0K | $100.0K | $38.0K | $200.0K | $200.0K | ||
| Amortization | -- | -- | $400.0K | $-1.8M | $-1.3M | $1.7M | $1.5M | $38.0K | $12.3M | $10.5M | ||
| Other Operating Expenses | -- | -- | -- | -- | $-160.8K | $345.0K | $393.0K | $493.0K | $460.0K | $456.0K | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-11.0M | $-16.1M | $13.9M | $-35.5M | $-17.4M | $-72.8M | $-82.1M | $-37.4M | $-27.4M | $-68.5M | ||
| EBITDA | $-10.5M | $-16.4M | $14.4M | $-30.5M | $-12.0M | $-45.5M | $-80.5M | $-35.9M | $-28.0M | $-38.2M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | -- | -- | -- | $2.4M | $4.2M | $3.4M | $-3.3M | ||
| Intinc | $519.8K | $-391.6K | $-53.6K | $41.3K | $121.3K | $49.0K | $-2.4M | $-4.2M | $-3.4M | $3.3M | ||
| Net Non-Operating Interest Income/Expense | $519.8K | $-391.6K | $-53.6K | $41.3K | $121.3K | $49.0K | $-2.4M | $-4.2M | $-3.4M | $3.3M | ||
| Gain on Sale of Securities | -- | -- | -- | -- | $53.9K | $5.2M | -- | -- | -- | -- | ||
| Other Income/Expense | -- | -- | $-18.1M | $-124.6K | $-1.3M | $-5.6M | $20.0K | $-20.0K | $42.0K | $-121.6M | ||
| Other Special Charges | -- | -- | -- | $124.6K | $1.2M | $409.0K | $-20.0K | $-20.0K | $-42.0K | $121.6M | ||
| SPECIAL ITEMS | ||||||||||||
| Special Income Charges | -- | -- | -- | -- | -- | -- | -- | -- | $-3.9M | -- | ||
| Impairment of Capital Assets | -- | -- | -- | -- | -- | -- | -- | -- | $3.9M | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-10.5M | $-16.5M | $13.8M | $-35.3M | $-16.0M | $-47.3M | $-82.2M | $-37.5M | $-31.5M | $-38.3M | ||
| Pre-Tax Income | $-10.5M | $-16.5M | $13.8M | $-35.3M | $-16.0M | $-63.7M | $-81.4M | $-41.6M | $-31.5M | $-35.0M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | -- | -- | $2.0M | $-49.5K | $280.3K | $-2.8M | $-196.0K | $28.0K | $14.0K | $114.0K | ||
| NET INCOME | ||||||||||||
| Net Income | $-10.5M | $-16.5M | $11.9M | $-35.3M | $-16.3M | $-63.5M | $-84.4M | $-41.7M | $-31.5M | $-35.1M | ||
| Net Income (Continuing Operations) | $-10.5M | $-16.5M | $11.9M | $-35.3M | $-16.3M | $-63.5M | $-84.4M | $-41.7M | $-31.5M | $-35.1M | ||
| Net Income (Discontinued Operations) | $-10.5M | $-16.5M | $11.9M | $-35.3M | $-16.3M | $-63.5M | $-84.4M | $-41.7M | $-31.5M | $-35.1M | ||
| Net Income (Common Stockholders) | $-10.5M | $-16.5M | $11.9M | $-35.3M | $-16.3M | $-57.6M | $-84.4M | $-41.7M | $-31.5M | $-35.1M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | $-81.6M | -- | -- | -- | ||
| TOTALS | ||||||||||||
| Total Expenses | $-11.0M | $-17.2M | $-14.6M | $32.3M | $24.1M | $77.8M | $86.0M | $55.5M | $24.1M | $41.3M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $772 | $735.9K | $1.5M | $2.9M | $135.6M | $4.1K | $582 | $39.2K | $277.7K | $4.4M | ||
| Average Shares Outstanding (Diluted) | $773 | $734.0K | $1.6M | $2.9M | $135.6M | $4.1K | $582 | $39.2K | $277.7K | $7.5M | ||
| Shares Outstanding | $3.0K | $895.4K | $2.6M | $3.6M | $20.0K | $30.9K | $39.2K | $55.0K | $13.2M | $10.7M | ||
| Basic EPS | -- | $-1.87 | $5.04 | $-14.4 | -- | $-14.9K | $-14.3K | $-1.1K | $-114 | $-7.94 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | -- | $-15.1K | $-14.3K | $-1.1K | $-114 | $-7.94 | ||
| Diluted EPS | $-13.6K | $-22.44 | $5.04 | $-14.4 | $0.12 | $-14.9K | $-14.3K | $-1.1K | $-114 | $-20.91 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | -- | -- | $-14.3K | $-1.1K | $-114 | $-20.91 | ||
| OTHER METRICS | ||||||||||||
| Basic Discontinuous Operations | -- | -- | -- | -- | -- | $201.6 | -- | -- | -- | -- | ||
| Net Income Discontinuous Operations | -- | -- | -- | -- | $8.0M | -- | -- | -- | -- | -- | ||
| Other Gand A | $4.4M | $7.1M | $7.9M | $10.5M | $10.1M | $17.4M | $24.7M | $20.7M | $10.3M | $17.2M | ||
| Other Impairment Of Capital Assets | -- | -- | -- | $-1.9M | $-1.4M | -- | -- | -- | -- | -- | ||
| Realized Capital Gain | -- | -- | $18.1M | $150.0K | -- | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $4.4M | $7.1M | $7.9M | $10.5M | $10.1M | -- | -- | -- | -- | -- | ||
| Selling Expense | -- | -- | $569.8K | $545.2K | $1.5M | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVTX | $11.70 | -1.1% | 262.02K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |